$NSTG $16.26 gap holding PR 10-Q sept 30, 2013
Post# of 63696
10-Q sept 30, 2013
NanoString Technologies Announces Adoption of the Prosigna Breast Cancer Assay by Leading US Clinical Laboratories and Cancer Centers
12/10/2013 6:01:00 PM - Business Wire